YM580
YM580 is a potent, orally active and selective Androgen Receptor (AR) antagonist (IC50 = 0.11 μM, hAR Ki = 4.6 nM, rAR Ki = 6.2 nM). YM580 exhibits good selectivity over PR, GR, and ERα (Kis > 3300 nM). YM580 decreases ventral prostate weight in mature intact rats dose-dependently without affecting serum testosterone levels. YM580 can be used for the research of prostate cancer.
For research use only. We do not sell to patients.
- CAS No.: 262295-11-4
- Formula: C21H19F6N5O
- Molecular Weight:471.41
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
|
hAR 4.6 nM (Ki) |
rAR 6.2 nM (Ki) |
rat PR 3300 nM (Ki) |
human GR >100000 nM (Ki) |
human ERα >100000 nM (Ki) |
YM580 potently inhibits AR-mediated transcriptional activation in AR/CHO#3 cells, with an IC50 of 0.11 μM[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Mature intact male Wistar rats (10-week-old)[1]
-
Dosage:0.3, 1, 3, 10, 30 mg/kg
-
Administration:p.o.; daily; 15 days
-
Result:Decreased ventral prostate weight in a dose-dependent manner with an ED50 of 2.2 mg/kg/day, and an inhibition rate of 67% at 10 mg/kg/day.
Exerted a maximum antiandrogenic effect comparable to surgical castration at 30 mg/kg/day.
Did not significantly elevate serum testosterone levels across all doses.
Exhibited good peripheral selectivity.
Chemical Information
-
CAS No. 262295-11-4
-
Molecular Weight 471.41
-
Formula C21H19F6N5O
-
SMILES
C[C@@H]1N(C2=CC(C(F)(F)F)=C(C#N)C=C2)C[C@@H](C)N(C(NC=3C=CC(C(F)(F)F)=NC3)=O)C1
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)